Improving Glycemic Control in DM2 Patients in the Ambulatory Setting

NACompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

August 16, 2021

Primary Completion Date

July 9, 2024

Study Completion Date

July 9, 2024

Conditions

Diabetes Mellitus

Interventions

DEVICE

Smart insulin pens and CGM

Participants in this group will be monitored by Smart Insulin pens and Continuous Glucose Monitoring Devices

OTHER

Point of Care Glucose Group

Participants in this group will be monitored by POC glucose values.

Trial Locations (1)

Baltimore VA Medical Center, Baltimore

All Listed Sponsors

lead

University of Maryland, Baltimore

OTHER

NCT04800471 - Improving Glycemic Control in DM2 Patients in the Ambulatory Setting | Biotech Hunter | Biotech Hunter